6 Drug Stocks Unworthy of Biotech Bull Market

Description:

According to Adam Feuerstein, here are "six biotech and drug stocks with valuations reaching unsustainable levels or which, for various reasons, don't deserve an invitation to the biotech bull market party at all." Read more here.

>>Also: 6 Stocks With Double-Digits Gains and Big Dividends

>>Also: 3 Tech Turnaround Stocks for 2012

Most Viewed Portfolios

View All

Articles

7 Stocks Soaring on Big Volume

05.31.12 | 01:15 PM

WINDERMERE, Fla. (Stockpickr) -- Professional traders running mutual funds and hedge funds don’t just look at a stock’s price moves; they also ...

5 Blue-Chip Stocks to Avoid

05.31.12 | 12:28 PM

 BALTIMORE (Stockpickr) -- Yesterday was a nasty little reminder that Europe is still grabbing headlines, whether investors like it or not. T...

More Articles
blog comments powered by Disqus
Get started with stockpickr! Get recommendations from thousands of mutual funds, hedge funds, and others. Enter your favorite stocks now!
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter